EUVIMEDObjevte EUVIMED
Crossref

Safety of Single Preoperative Dose of Enoxaparin for Hepatectomy: A Study in a Country With Low Venous Thromboembolism Incidence

Thakerng Pitakteerabundit iD, Utcharee Intusoma iD, Nan-Ak Wiboonkhwan iD, Tortrakoon Thongkan iD

ANZ Journal of Surgery · 2025

DOI: 10.1111/ans.70168 ↗

At a glance

Journal article in ANZ Journal of Surgery, 2025. Written by Thakerng Pitakteerabundit and 3 co-authors. Institution: Department of Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. Major MEDLINE topics: Enoxaparin, Hepatectomy, Venous Thromboembolism, Anticoagulants. 24 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Postoperative venous thromboembolism (VTE) prophylaxis for hepatectomy is debated in low‐VTE incidence regions like Thailand due to bleeding risks. This study evaluated single‐dose preoperative enoxaparin safety for VTE prophylaxis, focusing on post‐hepatectomy hemorrhage (PHH).

Methods

This retrospective review compared VTE and PHH incidence before (no prophylaxis) and after implementation of a single preoperative dose of enoxaparin 40 mg for all patients undergoing elective hepatectomy in a center in Thailand. PHH and post‐hepatectomy liver failure (PHLF) were defined per International Study Group of Liver Surgery criteria. Factors associated with PHH were analyzed using logistic regression.

Results

One hundred eighty‐six patients underwent elective hepatectomy (mean age 58 years). Fifty‐two percent underwent major hepatectomy. PHLF occurred in 11% of patients. VTE occurred in 0% (0/96) of the pre‐protocol and 1.1% (1/90) of the post‐protocol group. PHH rate was 3.8%, with no difference between pre‐protocol (3/96) and post‐protocol groups (4/90). Factors associated with PHH were intraoperative transfusion > 2 units (OR 33.3; 95% CI 1.9–587.7) and PHLF (OR 17.2; 95% CI 2.1–140.8), but not enoxaparin (OR 1.9; 95% CI 0.3–12.8).

Conclusions

Single preoperative enoxaparin did not increase PHH risk in this low VTE incidence cohort and may be considered for VTE prophylaxis in similar populations.

Subjects

MeSH terms (MEDLINE)

EnoxaparinHepatectomyVenous ThromboembolismAnticoagulantsPreoperative CarePostoperative HemorrhagePostoperative ComplicationsHumansMiddle AgedMaleRetrospective StudiesFemaleIncidenceThailandAgedAdult

Author keywords

hepatectomypost‐hepatectomy hemorrhagevenous thromboembolism

Substances

EnoxaparinAnticoagulants

Authors and institutions

  • Department of Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
  • Division of Neurology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

ORCID profiles: Thakerng Pitakteerabundit, Utcharee Intusoma, Nan-Ak Wiboonkhwan, Tortrakoon Thongkan

Cite

APA

Pitakteerabundit, T., Intusoma, U., Wiboonkhwan, N. A., & Thongkan, T. (2025). Safety of Single Preoperative Dose of Enoxaparin for Hepatectomy: A Study in a Country With Low Venous Thromboembolism Incidence. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70168

Vancouver

Pitakteerabundit T, Intusoma U, Wiboonkhwan NA, Thongkan T. Safety of Single Preoperative Dose of Enoxaparin for Hepatectomy: A Study in a Country With Low Venous Thromboembolism Incidence. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70168

BibTeX
@article{Pitakteerabundit2025,
  author = {Pitakteerabundit, Thakerng and Intusoma, Utcharee and Wiboonkhwan, Nan-Ak and Thongkan, Tortrakoon},
  title = {Safety of Single Preoperative Dose of Enoxaparin for Hepatectomy: A Study in a Country With Low Venous Thromboembolism Incidence},
  journal = {ANZ Journal of Surgery},
  year = {2025},
  doi = {10.1111/ans.70168}
}
Start for free →